• Gabriel Cuevas

    DVM, Ph.D., KU SUND

    Gabriel Cuevas DVM, PhD. I started my professional career in equine practice 20 years ago, and I have been working as an equine surgeon for the last 14 years. After working in Mexico, Australia and USA, I became Associate Professor of Equine Surgery at the University of Toulouse, France. Where I worked for 11 years. Additionally, I worked as a judiciary expert for the courthouse of Toulouse, I developed a platform for experimental surgery at the Institute of research in digestive health, and worked as a researcher for the same institution, and for a private laboratory Stroma-Lab. In addition, I worked in collaboration with Barcelona University, Spain for four years. My main clinical activities consist on large animal surgery, lameness exams, and ultrasonography. Concomitantly, I have been using clinically, mesenchymal stem cells and platelet rich plasma, as biotherapy for musculoskeletal pathology in equine athletes, for over ten years. Currently, I am working at Copenhagen University as Ass. Pr. of large animal surgery.

    Speaker til følgende sessioner
    • 13:20 - 14:00 Cell therapies, biologicals, biotherapy. Is it a better approach for musculoskeletal pathology?
      Biotherapy is defined as the use of living organisms as a treatment. These living organisms may be natural or produced in the laboratory. In the horse, the most common biotherapy is a concentrate of platelets (PRP) and/or mesenchymal stem cells (MSC). Their use in the horse is basically directed as a treatment for osteoarthritis (OA) and/or tendonitis (TEN). Biotherapies has been suggested for orthopedic equine therapy since the early 2000s. MSC and PRP have shown promise in the treatment of inflammatory musculoskeletal conditions including OA and TEN. The presentation will give and update on these therapies, from the literature point of view but also from clinical experience since 2005.
Cookies policy